Experimental Atrial Septal Defect Closure With a New, Transcatheter, Self-Centering Device follow-up.11 With the buttoned device, a cumbersome implantation technique with a 26% failure rate, structural failure characterized by "unbuttoning" in 10%, residual leaks in 39%, and embolization8,12 are obvious drawbacks. Despite two decades of research, a transcatheter technique for closure of atrial septal defects is not clinically available, and it is still an investigational technique. To overcome the drawbacks of these devices, we have designed a new device with a novel mechanism of closure, and we studied its efficacy in the closure of surgically created atrial septal defects in a canine model. The study protocol was approved by the Animal Care Committee of the University of Minnesota and conforms to the guiding principles of the American Physiological Society.
Methods
Device and Delivery System The device (Fig 1) consists of two square frames made of superelastic Nitinol wire (0.010-in. diameter) with a radiopaque marker wire of platinum wound around it. Each square frame has four "legs" that are interconnected by flexible eyelets at the corners. At the midpoint of each leg there is a flexible eyelet. The eight eyelets in each square frame function as torsion springs and permit the frame to be collapsed to load the device into FIG 1. Photograph ofthe atrial septal defect closure device shows two square-shaped disks made ofsuperelastic Nitinol wire, with knit elastic Dacron stretched taut and sewn over the frames. A circular hole has been punched out from the right atrial disk and the margin sewn onto the left atrial disk to form the "conjoint" ring (arrow).
the delivery catheter. The wire frames are covered by Dacron (polyester) fabric that has been specially developed for this device to have an element of elastic stretch. The fabric is stretched taut and sewn onto the frames. A circular hole, whose diameter is approximately half the size of the disk, is punched out from the right atrial disk. The margin of this orifice is sewn onto the fabric of the left atrial disk to form a conjoint ring (Fig 1) . The radial tension of the superelastic Nitinol wire frames and the apposed taut fabric sewn together along the conjoint ring keep both the disks closely apposed to each other. Each square frame can be collapsed by folding it so that the four corner eyelets are drawn close to each other (Fig 2) . The device is available in a range of sizes from 18 to 40 mm.
A special delivery system was designed to permit precise and reliable deployment of the device. It consists of a control handle (Fig 3) connected to a 10.5F delivery catheter. A "Y" connector interconnects the two to permit the delivery catheter to be flushed continuously with saline. A coaxial pusher runs inside the delivery catheter to its tip, and this is connected within the control handle to a rotary thumbscrew, which permits the tip to be drawn in or pushed out by rotating the thumbscrew. At the tip of the coaxial pusher, a short length of stainless steel tubing is incorporated (Fig 4) with a notch cut out. Within the lumen of this tube and the coaxial pusher runs a 0.014-in.-diameter Nitinol wire, from the tip all the way back to the control handle, where it is interconnected to a spring-loaded release trigger. To prevent accidental activation of the release trigger, a safety screw, which has to be loosened first, has been incorporated. On withdrawing the trigger, the Nitinol wire is drawn back in the notch of the release fixture. One of the corner eyelets of the right atrial disk (Fig 1) is positioned within the notch and the Nitinol wire is slid back through the eyelet, locking it in the release fixture, akin to a sliding bolt. The device frame is then collapsed (Fig 2) and loaded into the tip of the delivery catheter by turning the thumbscrew to draw the tip release fixture and device into the delivery catheter.
The basic mechanism of closure with this device is illustrated in a schematic manner in Fig 5. The delivery catheter, with the collapsed device loaded, is positioned across the atrial septal defect. The LA disk is opened in the LA and pulled against the atrial septum. The RA disk is then deployed in the RA. The release of the RA disk causes the superelastic Nitinol frames to stretch out the conjoint ring. The The animals were anesthetized by administering sodium pentobarbital (20 mg/kg) intravenously. They were intubated and mechanically ventilated with a Harvard ventilator. A right thoracotomy was performed, and the heart was exposed. A vertical incision was made in the pericardium, anterior and parallel to the right phrenic nerve with a T extension anteriorly. The right atrial appendage was clamped, a purse string suture was applied, and the tip of the appendage was excised. A second purse string suture was applied to the right atrial wall. The punch was introduced through the right atrial wall through the purse string suture. The left index finger was passed through the right atrial appendage and was used to palpate the fossa ovalis and correctly position the punch. The trocar of the punch was extruded outside the protective barrel on rotation of the screw knob by an assistant. This was then forcibly pushed across the atrial septum, and the atrial septum was seated in the slot of the trocar. On rotating the screw knob and returning the trocar to its original position, a clean circular hole was punched out in the atrial septum (Fig 6) . We used either a 10-mm or 7.5-mm punch in all the studies, and this permitted the creation of atrial septal defects of precise sizes. The purse string sutures were tied off, the pericardial incision was repaired, and the chest was closed in layers. The atrial septal defects created in this manner are approximately the same diameter as the punch. To establish the validity of this model, 8 balloon catheter (Arrow International Inc, Reading, Pa) or a 7F Fogarty catheter (American Edwards Laboratories, Anasco, Puerto Rico) was used to cross the atrial septal defect and size the defect. An 11F, 76-cm-long delivery sheath (USCI, CR Bard Inc) was then passed over the exchange wire, and the tip of the sheath was positioned in the left atrium. The device sizes were selected to achieve a device to stretched atrial septal defect diameter (D/D) ratio of approximately 2:1. The device, preloaded in its 1O.5F delivery catheter, was introduced into the long sheath through the Touhy Borst adapter and passed to the tip of the outer sheath in the left atrium (Fig 7, panel A) . By rotating the thumbscrew, the LA disk was then extruded (Fig 7, panel B) until the disk opened fully, and the whole sheath assembly was gently pulled back until the LA disk snagged on the atrial septum. While gentle traction was applied to the delivery catheter, the thumbscrew was rotated until the RA disk was extruded and deployed. The safety screw of the release trigger was loosened, and the trigger was activated to release the device. The implanted device self-centers around the atrial septal defect because of the conjoint ring, and both disks are tightly apposed to the atrial septum (Fig 7 , panels C and D). Right atrial angiography was then performed, with follow-through of the pulmonary levo phase to opacify the left atrium and evaluate any left-to-right shunt.
Acute studies. Fourteen animals underwent acute studies. These were performed either immediately after the surgical creation of the atrial septal defect (n= 12) or after 6 months of follow-up (n=2). In these animals after transcatheter closure and angiography, the dogs were killed by injection of 400 mEq IV potassium chloride bolus. The chest was opened, and the heart was excised. The atria were opened, and the seating of the device and closure of the atrial septal defect were examined. Survival studies. In 6 animals, device closures were performed 5.1+2.2 months (range, 0.5 to 7 months) after the surgical creation of atrial septal defects. After device closure, these animals were allowed to recover and were followed for 4.7±3.0 months (range, 2 to 8 months).
Follow-up Evaluation
The follow-up studies in chronic models were performed at variable intervals. Three dogs were restudied 2 months after atrial septal defect closure. After angiography was performed, the dogs were euthanized, both atria were opened for gross examination, and the devices and surrounding atrial septum were subjected to histopathological examination. To study the effects of long-term implantation, 3 dogs were restudied at 7, 7, and 8 months after atrial septal defect closure. In 1 dog, angiography was performed at 8 months to evaluate a trivial shunt that had been present immediately after closure. Cinefluoroscopy was performed in the 2 other animals when initial closures were complete. The cinefilms were studied to evaluate device position and for any evidence of wire fractures. These 3 dogs are alive and are to be prospectively followed up for a period of 2 years.
Retrieval Studies
To assess the retrievability of these devices, 4 devices (22-mm sized) were released into the RA of 2 normal adult dogs. Three of these devices were dislodged with a catheter and embolized to the pulmonary artery. All these devices were attempted to be retrieved with a snare device ( 18 dogs with the LA disk opened fully in the LA and the RA disk opened fully in the RA. In the first study, the delivery system did not have a safety screw, and after the LA disk was deployed and was being drawn against the atrial septum, the release trigger was accidentally released, causing the RA disk to be prematurely released. One corner of the RA disk straddled the atrial septal defect, with the other three in the RA. Nevertheless, the fully open LA disk occluded the defect and closed the shunt. The device was stable and did not embolize. After the first study, a safety screw was incorporated in the release trigger, and this problem has not recurred.
Angiography
Angiographic left-to-right shunts were present in all the 20 dogs before the closures. In the 19 successful closures, trivial residual shunts were seen in only 2 instances, immediately after closure. One of the 2 animals was followed chronically. Angiography after 8 months showed no shunt.
Complications
One study of the 20 was associated with complications. This was characterized by transient, generalized, ST segment depression and T wave inversions on the ECG, when the delivery catheter was being introduced coaxially into the long delivery sheath. The exact cause was not clear but probably was due to air embolism through the long sheath. In subsequent studies, with meticulous attention to clamping of sheaths with a rubber-shod hemostat and continuous flushing of the sheath and delivery catheter with saline, similar complications have not been encountered. 
Follow-up Studies and Histopathology
In the 6 survival studies, 3 dogs underwent angiography 8 weeks after closure and then were euthanized. There were no residual shunts, embolization of devices, or wire fractures. On opening the atria, the devices were found to be covered by a glistening, smooth, grayish endocardium, which was smoothly continuous with the surrounding atrial wall. There were no thrombi seen adherent to the device or on the atrial wall. The fabric patches and frames were intimately adhered to the atrial septum and could not be separated from the septum (Fig 8) . The atrial septum was excised with the device in place, and wedges of tissue including the implant and normal adjacent atrial septum were cut out and subjected to histopathological examination. This showed a smooth continuation of the endocardium from the atrial wall onto the surface of the patch. The luminal surface of the patch was covered by a thick layer of dense mature collagenous tissue underlying the endocardium (Fig 9) . The fabric fibers were seen with large diameters, pale staining, and enmeshed in collagen tissue (Fig 10) . The device evaluated in this report was designed with the principal aims of overcoming the problems of centering of the device in the atrial septal defect and for the device to be tightly self-occluding. To achieve this, three features were incorporated: (1) oversized LA and RA disks, (2) both disks being closely apposed to the atrial septum after deployment, with no potential spaces between the disks and atrial septum, and (3) a conjoint ring between the fabric disks. The conjoint ring plays a very important role. If a D/D ratio of 2 is used, the conjoint ring diameter is approximately equal to the stretched diameter of the ASD. On deployment of both disks, the radial tension of the superelastic wire frames stretches out the fabric and opens the conjoint ring. The ring approximates the edges of the defect and stretches the atrial septal defect to permit a tight and effective seal. In addition, the conjoint ring self-centers the device. Since it self-centers in the defect, small D/D ratios of up to 1.7 are effective. This is a potential advantage in the closure of large defects in children.
To make the deployment process reliable, the device was designed with a number of features. The first was to prevent "coning" of the deployed LA disk due to the axial traction used when it is drawn against the atrial septum. This prevents the device from being pulled through the defect because of a reduction in the D/D ratio during the process of coning. In this device, axial traction does not readily cause the frame to collapse. By design, due to the orientation of the eyelets, radial forces can more easily collapse the frame than axial traction, and no radial forces are actually involved in the deployment process. In addition, once the LA disk is deployed, the connection to the RA disk and delivery system is by elastic fabric. When the LA disk is drawn against the atrial septum, it snags, and any further traction draws the tip of the delivery catheter away from the LA disk by stretching the elastic fabric. This again prevents the frame from being collapsed and instead, the elastic fabric stretches out. On releasing tension, the tip of the delivery catheter, with the RA disk still in the catheter, moves back to approximate the LA disk because of the elastic fabric. In addition, the delivery system has been so designed that the entire deployment process is controlled from the control handle, enabling the deployment of the device to be precise and controlled.
The frame is made of superelastic Nitinol. Nitinol is a nickel titanium alloy composed of almost equal parts of the two metals and is available in a thermal shape memory alloy form14 or a superelastic form, depending on the exact composition of the alloy.15 The thermal shape memory alloy wire is currently used in the Simon vena cava filter14,16 and was earlier used as coil stents in animal models.17'18 The thermal shape memory permits the metal to be extremely pliable at low temperatures14 and returns to its annealed shape on rewarming to a temperature just above the phase-change temperature (at body temperature) with great rapidity and considerable force. In the high temperature phase, the wire is rigid. However, the introduction of these devices requires the perfusion of ice cold saline through the delivery sheath, and rewarming occurs on release into the warm blood stream. To simplify the implantation procedure, we chose to use the superelastic form of Nitinol wire. After annealing at 500°C on a preformed jig for 30 minutes and cooling to room temperature, the wire can be deformed to any shape but immediately returns to its preprogrammed annealed shape on re- lease. The biocompatibility of Nitinol alloy as an implant material has been established in experimental studies,19'20 and no problems have been encountered in the Simon inferior vena cava filter, which is made of Nitinol. 16 Nitinol has characteristics of resistance to corrosion, oxidation, and abrasion,14 reasons for its biocompatibility.
The fabric used for this device is Dacron (polyester), specially knit to permit elastic stretch. The inert nature of Dacron with a minimal inflammatory reaction, excellent healing by 8 In the clinical use of the clamshell device,7 these two techniques are not used, and RA angiography and echocardiography have been used. We did not use transthoracic and transesophageal echocardiography because in our earlier experience22 we found that because of the surgical thoracotomy performed to create the atrial septal defects, a significant amount of air is present in the mediastinum and pleural cavities in the acute studies. This resulted in a poor quality of images that was considered suboptimal for assessing small shunts. Hence, we performed RA angiography with follow-through of the pulmonary levo phase in both acute and chronic studies to use the same technique in both groups. The opacification of the LA was found to be good, with a reasonable assessment of left-to-right shunting. Interestingly, the demonstration of complete closures of small atrial septal defects in 100% of the experimental studies with the buttoned device,8 using transesophageal echocardiography, was not a predictor of the results in further clinical evaluations,12 where residual shunts after closure of larger defects have been reported in as much as 39% of cases. Hence, because of inherent limitations of the animal model that we have used, the small size of atrial septal defects occluded, and limitations of the technique of evaluation of closures used, the efficacy of closure in larger atrial septal defects can only be established in clinical trials.
In the present study, no structural failure of this device was encountered because the two fabric disks are firmly sewn to each other. There was a solitary instance of a wire fracture of one of the devices during the period of follow-up. The more muscular atria seen in dogs presumably subjects these devices to a greater degree of stress than is likely to be seen in humans. Nitinol has excellent resistance to fatigue,'4 and the elasticity of superelastic Nitinol is nearly 100%.15 With a quality delivery system in a canine model and to gather prelimcontrol step to exclude nicked or flawed wire frames ana the use of a thicker wire (0.012 in.) in humans with a more compliant atrial septum,9 it is probable that wire fractures will be rare. The drawback of this device is that it is currently delivered through an 11F delivery sheath and hence cannot be used in children less than 8 kg in weight. With improvements in its design and construction, it may be possible to further miniaturize the device and the delivery system to use smaller-size sheaths.
Conclusions
The 
